Literature DB >> 9133419

Positive and negative CD4+ thymocyte selection by a single MHC class II/peptide ligand affected by its expression level in the thymus.

Y Fukui1, T Ishimoto, M Utsuyama, T Gyotoku, T Koga, K Nakao, K Hirokawa, M Katsuki, T Sasazuki.   

Abstract

The central event in thymic selection of T cells bearing alpha beta TCRs is their interaction with self-peptides bound to self-MHC molecules. With the use of transgenic mouse lines expressing a single peptide/MHC class II complex, we show that CD4+ T cells with the preferential usage of particular TCR V(alpha)s and V(beta)s were selected to mature on this complex in lines with the lower expression, whereas such CD4+ T cells were eliminated in the thymus in a line with the relatively high expression. When a low expressing line was crossed with a high expressing line, the frequency of CD4+ T cells selected by this complex markedly decreased. Thus, these results suggest that a single peptide/MHC class II complex, being affected by its cell surface density in the thymus, can serve as both positively and negatively selecting ligand in vivo.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9133419     DOI: 10.1016/s1074-7613(00)80283-6

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  27 in total

Review 1.  Role of self-major histocompatibility complex/peptide ligands in selection and maintenance of a diverse T cell repertoire.

Authors:  C D Surh; B Ernst; D S Lee; W Dummer; E LeRoy
Journal:  Immunol Res       Date:  2000       Impact factor: 2.829

2.  Diversity of T cell repertoire shaped by a single peptide ligand is critically affected by its amino acid residue at a T cell receptor contact.

Authors:  Y Fukui; T Oono; J P Cabaniols; K Nakao; K Hirokawa; A Inayoshi; T Sanui; J Kanellopoulos; E Iwata; M Noda; M Katsuki; P Kourilsky; T Sasazuki
Journal:  Proc Natl Acad Sci U S A       Date:  2000-12-05       Impact factor: 11.205

3.  Positive selection of self-MHC-reactive T cells by individual peptide-MHC class II complexes.

Authors:  Gregory M Barton; Courtney Beers; Paul deRoos; Susan R Eastman; Marcela E Gomez; Katherine A Forbush; Alexander Y Rudensky
Journal:  Proc Natl Acad Sci U S A       Date:  2002-05-14       Impact factor: 11.205

4.  Altered positive selection due to corecognition of floppy peptide/MHC II conformers supports an integrative model of thymic selection.

Authors:  Christophe Viret; Xin He; Charles A Janeway
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-16       Impact factor: 11.205

Review 5.  Selection of self-reactive T cells in the thymus.

Authors:  Gretta L Stritesky; Stephen C Jameson; Kristin A Hogquist
Journal:  Annu Rev Immunol       Date:  2011-12-05       Impact factor: 28.527

6.  Experimental autoimmune encephalomyelitis in mice expressing the autoantigen MBP 1-10 covalently bound to the MHC class II molecule I-Au.

Authors:  Florian C Kurschus; Thilo Oelert; Birgit Liliensiek; Pascale Buchmann; David C Wraith; Günter J Hämmerling; Bernd Arnold
Journal:  Int Immunol       Date:  2005-12-16       Impact factor: 4.823

7.  Paradoxical intrathymic positive selection in mice with only a covalently presented agonist peptide.

Authors:  C Viret; X He; C A Janeway
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-24       Impact factor: 11.205

8.  Organ-specific autoimmunity in mice whose T cell repertoire is shaped by a single antigenic peptide.

Authors:  T Oono; Y Fukui; S Masuko; O Hashimoto; T Ueno; T Sanui; A Inayoshi; M Noda; M Sata; T Sasazuki
Journal:  J Clin Invest       Date:  2001-12       Impact factor: 14.808

9.  Impaired expression of MHC class II molecules in response to interferon-gamma (IFN-gamma) on human thymoma neoplastic epithelial cells.

Authors:  M Inoue; M Okumura; S Miyoshi; H Shiono; K Fukuhara; Y Kadota; R Shirakura; H Matsuda
Journal:  Clin Exp Immunol       Date:  1999-07       Impact factor: 4.330

10.  Recurrent genetic aberrations in thymoma and thymic carcinoma.

Authors:  A Zettl; P Ströbel; K Wagner; T Katzenberger; G Ott; A Rosenwald; K Peters; A Krein; M Semik; H K Müller-Hermelink; A Marx
Journal:  Am J Pathol       Date:  2000-07       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.